Clinical trial
Phase II Study of Sunitinib in Metastatic Renal Cancer With Non-clear Cell Histology
NCT01034878 is registered in ClinicalTrials.gov with Istituto Clinico Humanitas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Sunitinib in Metastatic Renal Cancer With Non-clear Cell Histology
- Lead sponsor
- Istituto Clinico Humanitas
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- December 31, 2014
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.